Under the microscope: Regeneus (ASX:RGS) - Leo Lee, Chief Executive Officer

from Morgans Under the Microscope · host Morgans Financial Limited

Morgans analyst Iain Wilkie sat down with Leo Lee, CEO of ASX listed regenerative medicine player Regeneus (ASX:RGS). The two speak on its recent partnership deal for osteoarthritis in Japan and what it means for the company.

Episode metadata supplied by the publisher feed · Published Aug 18, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Under the microscope: Regeneus (ASX:RGS) - Leo Lee, Chief Executive Officer

0:00 8:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Morgans Under the Microscope?

This episode is 8 minutes long.

When was this Morgans Under the Microscope episode published?

This episode was published on August 18, 2020.

Can I download this Morgans Under the Microscope episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!